Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2005 1
2006 2
2007 1
2008 3
2009 2
2010 2
2012 2
2013 2
2014 2
2015 2
2017 2
2018 2
2019 1
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

31 results
Results by year
Filters applied: . Clear all
Page 1
Human Gut-Associated Natural Killer Cells in Health and Disease.
Poggi A, Benelli R, Venè R, Costa D, Ferrari N, Tosetti F, Zocchi MR. Poggi A, et al. Among authors: tosetti f. Front Immunol. 2019 May 3;10:961. doi: 10.3389/fimmu.2019.00961. eCollection 2019. Front Immunol. 2019. PMID: 31130953 Free PMC article. Review.
On arsenic and plague.
Tosetti F. Tosetti F. Clin Infect Dis. 2014 Dec 15;59(12):1806-8. doi: 10.1093/cid/ciu704. Epub 2014 Sep 2. Clin Infect Dis. 2014. PMID: 25182246 No abstract available.
Synthesis and in vitro Evaluation of ADAM10 and ADAM17 Highly Selective Bioimaging Probes.
Camodeca C, Nuti E, Tosetti F, Poggi A, D'Arrigo C, Zocchi MR, Rossello A. Camodeca C, et al. Among authors: tosetti f. ChemMedChem. 2018 Oct 8;13(19):2119-2131. doi: 10.1002/cmdc.201800482. Epub 2018 Sep 12. ChemMedChem. 2018. PMID: 30102846
Cancer prevention by targeting angiogenesis.
Albini A, Tosetti F, Li VW, Noonan DM, Li WW. Albini A, et al. Among authors: tosetti f. Nat Rev Clin Oncol. 2012 Sep;9(9):498-509. doi: 10.1038/nrclinonc.2012.120. Epub 2012 Jul 31. Nat Rev Clin Oncol. 2012. PMID: 22850752 Review.
Specific ADAM10 inhibitors localize in exosome-like vesicles released by Hodgkin lymphoma and stromal cells and prevent sheddase activity carried to bystander cells.
Tosetti F, Venè R, Camodeca C, Nuti E, Rossello A, D'Arrigo C, Galante D, Ferrari N, Poggi A, Zocchi MR. Tosetti F, et al. Oncoimmunology. 2018 Jan 19;7(5):e1421889. doi: 10.1080/2162402X.2017.1421889. eCollection 2018. Oncoimmunology. 2018. PMID: 29721369 Free PMC article.
Tumor inflammatory angiogenesis and its chemoprevention.
Albini A, Tosetti F, Benelli R, Noonan DM. Albini A, et al. Among authors: tosetti f. Cancer Res. 2005 Dec 1;65(23):10637-41. doi: 10.1158/0008-5472.CAN-05-3473. Cancer Res. 2005. PMID: 16322203 Free article. Review.
The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer.
Brizzolara A, Benelli R, Venè R, Barboro P, Poggi A, Tosetti F, Ferrari N. Brizzolara A, et al. Among authors: tosetti f. Cancer Lett. 2017 Aug 1;400:9-17. doi: 10.1016/j.canlet.2017.04.025. Epub 2017 Apr 25. Cancer Lett. 2017. PMID: 28450158
Anti-angiogenic properties of chemopreventive drugs: fenretinide as a prototype.
Sogno I, Venè R, Sapienza C, Ferrari N, Tosetti F, Albini A. Sogno I, et al. Among authors: tosetti f. Recent Results Cancer Res. 2009;181:71-6. doi: 10.1007/978-3-540-69297-3_8. Recent Results Cancer Res. 2009. PMID: 19213559 Review.
Angioprevention with fenretinide: targeting angiogenesis in prevention and therapeutic strategies.
Sogno I, Venè R, Ferrari N, De Censi A, Imperatori A, Noonan DM, Tosetti F, Albini A. Sogno I, et al. Among authors: tosetti f. Crit Rev Oncol Hematol. 2010 Jul;75(1):2-14. doi: 10.1016/j.critrevonc.2009.10.007. Epub 2010 Jan 19. Crit Rev Oncol Hematol. 2010. PMID: 20034809 Review.
Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activity.
Zocchi MR, Costa D, Venè R, Tosetti F, Ferrari N, Minghelli S, Benelli R, Scabini S, Romairone E, Catellani S, Profumo A, Poggi A. Zocchi MR, et al. Among authors: tosetti f. Oncoimmunology. 2017 Jan 6;6(3):e1278099. doi: 10.1080/2162402X.2016.1278099. eCollection 2017. Oncoimmunology. 2017. PMID: 28405500 Free PMC article.
31 results
Jump to page